Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma | Canada Hyperbarics Skip to main content
Case Report Int J Part Ther 2022

Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma

Puthenpura V, DeNunzio N, Zeng X, Giantsoudi D, Aboian M, Ebb D, et al. — Int J Part Ther, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case study of a 5-year-old boy with Aarskog-Scott syndrome who developed medulloblastoma and subsequent brainstem radiation necrosis after proton therapy.

What They Found

A 5-year-old male with Aarskog-Scott syndrome and medulloblastoma developed brainstem radiation necrosis following proton beam radiation therapy. After treatment with high-dose dexamethasone, bevacizumab, and hyperbaric oxygen therapy, the patient showed radiographic improvement and clinical stabilization.

Canadian Relevance

This study covers delayed radiation injury, which is a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

This was a single case report, meaning its findings cannot be generalized to a larger population without further research.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Radiation Injury
Source Pubmed
PubMed ID 35127977
Year Published 2022
Journal Int J Part Ther

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology